STARTUP LEGAL2 Oct 2026
Jyothy Labs has cash to buy growth. Why it isn’t rushing | Company Business News
Henkel ended its 15-year licence for Pril and Fa in May, leaving Jyothy Labs with a portfolio gap. The firm holds ₹997 crore cash and no debt, yet it won't rush into buying brands. Instead it is building new products and stronger brands like Margo. Profit fell 10% to ₹333 crore last year, since 80-85% of its products use crude-linked inputs.
Key Statutory Highlights
- Henkel ended its 15-year licensing arrangement for Pril and Fa in May, so Jyothy Labs has to rebuild that part of its portfolio.
- Jyothy Labs has ₹997 crore in cash and no debt, but managing director M.R. Jyothy said she does not want to rush into acquisitions that could cause problems for years.
- Net profit fell 10% to ₹333 crore in the year ended March 2026 even as revenue rose 3.5% to ₹2,944 crore, and operating margin slipped to 8.4% in Q1FY27 from 17.4% in FY24.
Actionable Advice for Taxpayers / Founders:If your business relies on licensed brands or crude-linked raw materials, review those contracts and input costs early, and check with your chartered accountant before committing to any large acquisition.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: